ANDA 77878, held by Strides Pharma International. Metoclopramide Hydrochloride.
As of Nov 21, 2026, ANDA 77878 (Metoclopramide Hydrochloride), held by Strides Pharma International, was first approved by FDA on Aug 28, 2006, with 5 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Aug 28, 2006 | Original application | Approved | None posted |
| Metoclopramide HydrochlorideEQ 5MG BASE · tablet;oral | Metoclopramide Hydrochloride | Rx |
| Metoclopramide HydrochlorideEQ 10MG BASE · tablet;oral | Metoclopramide Hydrochloride | Rx |
| Jul 16, 2019 | Supplement 12Labeling · Standard review | Approved | None posted |
| Aug 13, 2012 | Supplement 5Labeling | Approved | None posted |
| Feb 28, 2011 | Supplement 4Labeling | Approved | None posted |
| Apr 30, 2010 | Supplement 2Labeling | Approved | None posted |
| Apr 30, 2010 | Supplement 3Labeling | Approved | None posted |
| Aug 28, 2006 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters